Meet with the Researchers Behind Two New Exciting JM Drugs

Hear directly from the researchers behind two of the most exciting new treatments for juvenile myositis (JM). You’ll learn details about two new treatments and what these drugs could mean for you and your child with JM.

Featuring:

  • Dr. Kaveh Ardalan of Duke University
  • Dr. Travis Kinder of the NIH
  • Jim Minow, Cure JM Executive Director

Doctor and young juvenile myositis patient.

What is Juvenile Myositis?

Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its own cells and tissues.

Juvenile Myositis 101

A world-renowned pediatric rheumatologist and immunologist tells us what juvenile dermatomyositis (JDM) is, how it is diagnosed, and how it is treated.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.